348 related articles for article (PubMed ID: 33922379)
1. Peptides to Tackle Leishmaniasis: Current Status and Future Directions.
Robles-Loaiza AA; Pinos-Tamayo EA; Mendes B; Teixeira C; Alves C; Gomes P; Almeida JR
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922379
[TBL] [Abstract][Full Text] [Related]
2. Current approaches to discover marine antileishmanial natural products.
Tempone AG; Martins de Oliveira C; Berlinck RG
Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
[TBL] [Abstract][Full Text] [Related]
3. Modes of action of Leishmanicidal antimicrobial peptides.
Marr AK; McGwire BS; McMaster WR
Future Microbiol; 2012 Sep; 7(9):1047-59. PubMed ID: 22953706
[TBL] [Abstract][Full Text] [Related]
4. Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties.
Corman HN; Ross JN; Fields FR; Shoue DA; McDowell MA; Lee SW
Microbiol Spectr; 2022 Dec; 10(6):e0265822. PubMed ID: 36342284
[TBL] [Abstract][Full Text] [Related]
5. Treatment of leishmaniasis: a review and assessment of recent research.
Elmahallawy EK; Agil A
Curr Pharm Des; 2015; 21(17):2259-75. PubMed ID: 25543123
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in antileishmanial drug development.
Davis AJ; Kedzierski L
Curr Opin Investig Drugs; 2005 Feb; 6(2):163-9. PubMed ID: 15751739
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial peptides for leishmaniasis.
Cobb SL; Denny PW
Curr Opin Investig Drugs; 2010 Aug; 11(8):868-75. PubMed ID: 20721829
[TBL] [Abstract][Full Text] [Related]
8. Plants as Antileishmanial Agents: Current Scenario.
Ullah N; Nadhman A; Siddiq S; Mehwish S; Islam A; Jafri L; Hamayun M
Phytother Res; 2016 Dec; 30(12):1905-1925. PubMed ID: 27704633
[TBL] [Abstract][Full Text] [Related]
9. Exploration of Antileishmanial Compounds Derived from Natural Sources.
Peer GDG; Priyadarshini A; Gupta A; Vibhuti A; Raj VS; Chang CM; Pandey RP
Antiinflamm Antiallergy Agents Med Chem; 2024; 23(1):1-13. PubMed ID: 38279725
[TBL] [Abstract][Full Text] [Related]
10. Promising therapeutic targets for antileishmanial drugs.
Werbovetz KA
Expert Opin Ther Targets; 2002 Aug; 6(4):407-22. PubMed ID: 12223057
[TBL] [Abstract][Full Text] [Related]
11. Need for sustainable approaches in antileishmanial drug discovery.
Hendrickx S; Caljon G; Maes L
Parasitol Res; 2019 Oct; 118(10):2743-2752. PubMed ID: 31473855
[TBL] [Abstract][Full Text] [Related]
12. A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis.
Sousa JKT; Antinarelli LMR; Mendonça DVC; Lage DP; Tavares GSV; Dias DS; Ribeiro PAF; Ludolf F; Coelho VTS; Oliveira-da-Silva JA; Perin L; Oliveira BA; Alvarenga DF; Chávez-Fumagalli MA; Brandão GC; Nobre V; Pereira GR; Coimbra ES; Coelho EAF
Parasitol Int; 2019 Dec; 73():101966. PubMed ID: 31362122
[TBL] [Abstract][Full Text] [Related]
13. In vitro leishmanicidal activity of antimicrobial peptide KDEL against Leishmania tarentolae.
Cao L; Jiang W; Cao S; Zhao P; Liu J; Dong H; Guo Y; Liu Q; Gong P
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1286-1292. PubMed ID: 31761925
[TBL] [Abstract][Full Text] [Related]
14. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
[TBL] [Abstract][Full Text] [Related]
15. Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
Tiwari N; Gedda MR; Tiwari VK; Singh SP; Singh RK
Mini Rev Med Chem; 2018; 18(1):26-41. PubMed ID: 28443518
[TBL] [Abstract][Full Text] [Related]
16. Eugenia piauhiensis Vellaff. essential oil and γ-elemene its major constituent exhibit antileishmanial activity, promoting cell membrane damage and in vitro immunomodulation.
Nunes TAL; Costa LH; De Sousa JMS; De Souza VMR; Rodrigues RRL; Val MDCA; Pereira ACTDC; Ferreira GP; Da Silva MV; Da Costa JMAR; Véras LMC; Diniz RC; Rodrigues KADF
Chem Biol Interact; 2021 Apr; 339():109429. PubMed ID: 33713644
[TBL] [Abstract][Full Text] [Related]
17. Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: a review.
Da Silva BJM; Hage AAP; Silva EO; Rodrigues APD
J Integr Med; 2018 Jul; 16(4):211-222. PubMed ID: 29691188
[TBL] [Abstract][Full Text] [Related]
18. A "Golden Age" for the discovery of new antileishmanial agents: Current status of leishmanicidal gold complexes and prospective targets beyond the trypanothione system.
Rosa LB; Aires RL; Oliveira LS; Fontes JV; Miguel DC; Abbehausen C
ChemMedChem; 2021 Jun; 16(11):1681-1695. PubMed ID: 33615725
[TBL] [Abstract][Full Text] [Related]
19. An Update on Natural Antileishmanial Treatment Options from Plants, Fungi and Algae.
Koko WS; Al Nasr IS; Khan TA; Schobert R; Biersack B
Chem Biodivers; 2022 Jan; 19(1):e202100542. PubMed ID: 34822224
[TBL] [Abstract][Full Text] [Related]
20. Insights into the current status of privileged N-heterocycles as antileishmanial agents.
Razzaghi-Asl N; Sepehri S; Ebadi A; Karami P; Nejatkhah N; Johari-Ahar M
Mol Divers; 2020 May; 24(2):525-569. PubMed ID: 31028558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
